Conversely, a reduction in the frequency of IL-10+ Bregs has been associated with hyperinflammatory responses in critical and severe COVID-19 patients, supported by an increase in clinical inflammatory parameters, including neutrophil/lymphocyte ratio and the D-dimer presence [109]. The gene discussed is IL10; the disease is COVID-19.